A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells

Inflammation Research

Volumn 67, Issue 6, 2018, Pages 539-551

  Yi, Gao ^a   Liang, Min ^a   Li, Ming ^a   Fang, Xiangming ^a   Liu, Jifang ^a   Lai, Yuxiong ^a   Chen, Jitao ^a   Yao, Wenxia ^a   Feng, Xiao ^a   Hu, La ^a   Lin, Chunyi ^a   Zhou, Xinke ^a   Liu, Zhaoyu ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Airway epithelial cells; COPD; IL1B; Inflammation

Indexed keywords

CC CHEMOKINE LIGAND 23; CHEMOKINE; CXCL14 CHEMOKINE; DUAL OXIDASE; DUAL OXIDASE 2; INTERLEUKIN 1BETA; MACROPHAGE ELASTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG; DUOX2 PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; IL1R2 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR TYPE II; MMP12 PROTEIN, HUMAN; TRANSCRIPTOME;

AIRWAY EPITHELIUM CELL; ARTICLE; BLOOD; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER MODEL; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE ONTOLOGY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG PARENCHYMA; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RESPIRATORY TRACT INFLAMMATION; SPUTUM; UPREGULATION; CYTOLOGY; EPITHELIUM CELL; GENETICS; INFLAMMATION; LUNG; METABOLISM;

CHEMOKINES; DUAL OXIDASES; EPITHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; LUNG; MATRIX METALLOPROTEINASE 12; PROTEIN INTERACTION MAPS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, INTERLEUKIN-1 TYPE II; TRANSCRIPTOME;

EID: 85044761505     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-018-1145-8     Document Type: Article

References (43)

1. Diaz-Guzman E, Mannino DM. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35:7–16.
2. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Ann Rev Pathol 2009;4:435–59.
3. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365:1567–75.
4. Tonnesen P. Smoking cessation. and COPD. Eur Respir Rev Off J Eur Respir Soc. 2013;22:37–43.
5. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49(3). 10.1183/13993003.00214-2017.
6. Goncalves RB, Coletta RD, Silverio KG, Benevides L, Casati MZ, da Silva JS, et al. Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm Res. 2011;60:409–24.
7. Kim WD, Ling SH, Coxson HO, English JC, Yee J, Levy RD, et al. The association between small airway obstruction and emphysema phenotypes in COPD. Chest. 2007;131:1372–8.
8. Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. Chest. 2013;143:1436–43.
9. Hogg JC, Pare PD, Hackett TL. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev. 2017;97:529–52.
10. Angelis N, Porpodis K, Zarogoulidis P, Spyratos D, Kioumis I, Papaiwannou A, et al. Airway inflammation in chronic obstructive pulmonary disease. J Thorac Dis. 2014;6(Suppl 1):S167–72.
11. Yang J, Zuo WL, Fukui T, Chao I, Gomi K, Lee B, et al. Smoking-dependent distal-to-proximal repatterning of the adult human small airway epithelium. Am J Respir Crit Care Med. 2017;196:340–52.
12. Shaykhiev R, Otaki F, Bonsu P, Dang DT, Teater M, Strulovici-Barel Y, et al. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell Mol Life Sci CMLS 2011;68:877–92.
13. Raman T, O’Connor TP, Hackett NR, Wang W, Harvey BG, Attiyeh MA, et al. Quality control in microarray assessment of gene expression in human airway epithelium. BMC Genom. 2009;10:493.
14. Ammous Z, Hackett NR, Butler MW, Raman T, Dolgalev I, O’Connor TP, et al. Variability in small airway epithelial gene expression among normal smokers. Chest. 2008;133:1344–53.
15. Morrow JD, Zhou X, Lao T, Jiang Z, DeMeo DL, Cho MH, et al. Functional interactors of three genome-wide association study genes are differentially expressed in severe chronic obstructive pulmonary disease lung tissue. Sci Rep. 2017;7:44232.
16. Singh D, Fox SM, Tal-Singer R, Plumb J, Bates S, Broad P, et al. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers. Thorax. 2011;66:489 – 95.
17. Davies C, Rhodes JA, Barnes P, Donnelly L. Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists. Eur Respir J. 2015;46(suppl 59):PA3900.
18. Abdel-Halim M, Darwish SS, ElHady AK, Hoppstadter J, Abadi AH, Hartmann RW, et al. Pharmacological inhibition of protein kinase C (PKC)zeta downregulates the expression of cytokines involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2016;93:405–9.
19. Qin S, Huleihel L, Lucht L, Clarke A, Ries JW, Kessinger C, et al. Alterations of inflammatory chemokine and matrix metalloproteinase mRNA levels in BAL cells from HIV-infected COPD patients. Am J Resp Crit Care. 2015;191:A4716.
20. Frankenberger M, Eder C, Hofer TP, Heimbeck I, Skokann K, Kassner G, et al. Chemokine expression by small sputum macrophages in COPD. Mol Med. 2011;17:762–70.
21. Eapen MS, Myers S, Walters EH, Sohal SS. Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox. Expert Rev Respir Med. 2017;11:827–39.
22. Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res Off J Eur Histamine Res Soc [et al]. 2008;57:497–503.
23. Vogelmeier C, Koczulla R, Fehrenbach H, Bals R. Pathogenesis of chronic obstructive pulmonary disease. Der Internist. 2006;47(6):885–6 (888–90, 892–4).
24. Szulakowski P, Mroz RM, Pierzchala W, Chyczewska E, MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Molecular mechanisms (part II). Wiad Lek. 2006;59:250–4.
25. McGuinness AJ, Sapey E. Oxidative stress in COPD: sources, markers, and potential mechanisms. J Clin Med. 2017;6(2):21.
26. Choudhury G, MacNee W. Role of inflammation and oxidative stress in the pathology of ageing in COPD: potential therapeutic interventions. Copd. 2017;14:122–35.
27. Malic Z, Topic A, Francuski D, Stankovic M, Nagorni-Obradovic L, Markovic B, et al. Oxidative stress and genetic variants of xenobiotic-metabolising enzymes associated with copd development and severity in serbian adults. Copd. 2017;14:95–104.
28. Meihua G, Jian W, Nanshan Z. [esearch progress of the role of oxidative stress in the pathogenesis of COPD. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chin J Tuberc Respir Dis. 2015;38:222–4.
29. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.
30. Barnes PJ. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov. 2013;12:543–59.
31. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. gold executive summary. Am J Respir Crit Care Med. 2017;195:557–82.
32. Barnes PJ. Inhaled corticosteroids in COPD: a controversy. Respir Int Rev Thorac Dis. 2010;80:89–95.
33. Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010;6:232–41.
34. Xie ZK, Huang QP, Huang J, Xie ZF. Association between the IL1B, IL1RN polymorphisms and COPD risk: a meta-analysis. Sci Rep. 2014;4:6202.
35. Mei JJ, Liang Y, Shen N, He B. Association between interleukin-1B polymorphisms and chronic obstructive pulmonary disease: a meta-analysis. Zhonghua yi xue za zhi. 2013;93:910–5.
36. Danilko KV, Korytyna GF, Akhmadishina LZ, Yanbaeva DG, Zagidullin SZ, Victorova TV. Association of polymorphisms of cytokine genes (IL1B, IL1RN, TNFA, LTA, IL6, IL8, and IL10) with chronic obstructive pulmonary disease. Mol Biol. 2007;41:22–31.
37. Mahajan B, Vijayan VK, Agarwal MK, Bansal SK. Serum interleukin-1beta as a marker for differentiation of asthma and chronic obstructive pulmonary disease. Biomarkers. 2008;13:713–27.
38. Hammad DR, Elgazzar AG, Essawy TS, Sameie SA. Evaluation of serum interleukin-1 beta as an inflammatory marker in copd patients. Egypt J Chest Dis Tuberc. 2015;64:347–52.
39. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Ann Rev Immunol. 2009;27:519–50.
40. Skerrett SJ, Liggitt HD, Hajjar AM, Ernst RK, Miller SI, Wilson CB. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol. 2004;287:L143–52.
41. Hellermann GR, Nagy SB, Kong X, Lockey RF, Mohapatra SS. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res. 2002;3:22.
42. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, et al. Succinate is an inflammatory signal that induces il-1β through hif-1α. Nature. 2013;496(7444):238–42.
43. Hashimoto K, Oreffo RO, Gibson MB, Goldring MB, Roach HI. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum. 2009;60:3303–13.